Rachel Kendrick

Rachel has more than 14 years’ experience in publications and scientific communications, in the pharmaceutical industry and the medical communications field. Within AstraZeneca, she is responsible for publication planning, strategy and delivery across all products and disease areas within the late-stage cardiovascular, renal and metabolism (CVRM) therapy area. Rachel, along with her team, leads a number of cross-functional initiatives focusing on Patient Involvement in Publications, Clinical Trial Transparency, and optimizing enhanced publication content.